Cargando…
Correction to: How do patients interpret and respond to a single‑item global indicator of cancer treatment tolerability?
Autores principales: | Peipert, John Devin, Shaunfield, Sara, Kaiser, Karen, Moreno, Patricia I., Fox, Rina S., Kircher, Sheetal, Mohindra, Nisha, Ip, Edward, Zhao, Fengmin, Wagner, Lynne, Cella, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366021/ https://www.ncbi.nlm.nih.gov/pubmed/37486453 http://dx.doi.org/10.1007/s00520-023-07953-7 |
Ejemplares similares
-
How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?
por: Peipert, John Devin, et al.
Publicado: (2022) -
Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale
por: Kaiser, Karen, et al.
Publicado: (2020) -
Validity of a single-item indicator of treatment side effect bother in a diverse sample of cancer patients
por: Griffiths, Pip, et al.
Publicado: (2022) -
General population reference values for the Functional Assessment of Cancer Therapy‐Lung and PROMIS‐29
por: Mohindra, Nisha A., et al.
Publicado: (2023) -
Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ(©))
por: Kaiser, Karen, et al.
Publicado: (2020)